Theravance Biopharma, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Theravance Biopharma, Inc. (TBPH) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.00 million shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-08-13
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.00M shares, a 48.25% decline year-over-year.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 3.59M shares, a 3.70% increase year-over-year.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 3.87M shares, a 4.66% increase year-over-year.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 3.26M shares, a 23.97% decline year-over-year.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.92M shares, a 28.63% decline from fiscal 2022.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.49M shares, a 61.21% decline from fiscal 2021.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 14.14M shares, a 6.92% increase from fiscal 2020.
- Theravance Biopharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 13.23M shares, a 0.18% decline from fiscal 2019.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2025-06-30 | 2.00M shares 10-Q · filed 2025-08-13 | 800.00K shares 10-Q · filed 2025-08-13 | ||||
| 2024-09-30 | 3.59M shares 10-Q · filed 2024-11-14 | 3.58M shares 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | 3.87M shares 10-Q · filed 2024-08-08 | 3.26M shares 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | 3.26M shares 10-Q · filed 2024-05-15 | |||||
| 2023-12-31 | 3.92M shares 10-K · filed 2024-03-01 | |||||
| 2023-09-30 | 3.46M shares 10-Q · filed 2024-11-14 | 3.97M shares 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | 3.69M shares 10-Q · filed 2024-08-08 | 4.11M shares 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | 4.29M shares 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | 5.49M shares 10-K · filed 2024-03-01 | |||||
| 2022-09-30 | 5.04M shares 10-Q · filed 2022-11-09 | 7.14M shares 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | 12.34M shares 10-Q · filed 2023-08-09 | 12.91M shares 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | 13.51M shares 10-Q · filed 2023-05-10 | |||||
| 2021-12-31 | 14.14M shares 10-K · filed 2023-03-01 | |||||
| 2021-09-30 | 15.58M shares 10-Q · filed 2022-11-09 | 14.98M shares 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | 12.90M shares 10-Q · filed 2022-08-08 | 14.98M shares 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | 15.16M shares 10-Q · filed 2022-05-06 | |||||
| 2020-12-31 | 13.23M shares 10-K · filed 2023-03-01 | |||||
| 2020-09-30 | 14.74M shares 10-Q · filed 2021-11-08 | 13.24M shares 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | 12.39M shares 10-Q · filed 2021-08-05 | 12.42M shares 10-Q · filed 2021-08-05 | ||||
| 2020-03-31 | 12.71M shares 10-Q · filed 2021-05-06 | |||||
| 2019-12-31 | 13.25M shares 10-K · filed 2022-02-28 | |||||
| 2019-09-30 | 14.02M shares 10-Q · filed 2020-11-09 | 13.17M shares 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | 14.14M shares 10-Q · filed 2020-08-10 | 12.90M shares 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | 12.16M shares 10-Q · filed 2020-05-08 | |||||
| 2018-12-31 | 10.17M shares 10-K · filed 2021-02-26 | |||||
| 2018-09-30 | 10.46M shares 10-Q · filed 2018-11-08 | 11.42M shares 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | 10.46M shares 10-Q · filed 2019-11-08 | 12.06M shares 10-Q · filed 2018-08-02 | 11.30M shares 10-Q · filed 2019-08-05 | |||
| 2018-03-31 | 10.60M shares 10-Q · filed 2019-05-10 | |||||
| 2017-12-31 | 10.05M shares 10-K · filed 2020-02-27 | |||||
| 2017-09-30 | 9.77M shares 10-Q · filed 2018-11-08 | 9.78M shares 10-Q · filed 2018-11-08 | ||||
| 2017-06-30 | 9.38M shares 10-Q · filed 2018-08-02 | 9.66M shares 10-Q · filed 2018-08-02 | ||||
| 2017-03-31 | 10.09M shares 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | 10.42M shares 10-K · filed 2019-02-28 | |||||
| 2016-09-30 | 3.64M shares 10-Q · filed 2017-11-08 | 3.53M shares 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | 4.80M shares 10-Q · filed 2017-08-09 | 4.91M shares 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | 5.63M shares 10-Q · filed 2017-05-10 | |||||
| 2015-12-31 | 4.74M shares 10-K · filed 2018-02-28 | |||||
| 2015-09-30 | 6.89M shares 10-Q · filed 2016-11-09 | 6.56M shares 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | 6.94M shares 10-Q · filed 2016-08-09 | 4.66M shares 10-Q · filed 2016-08-09 | ||||
| 2015-03-31 | 4.75M shares 10-Q · filed 2016-05-10 | |||||
| 2014-12-31 | 3.90M shares 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | 4.04M shares 10-Q · filed 2015-11-12 | 3.93M shares 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | 1.97M shares 10-Q · filed 2015-08-13 | 2.46M shares 10-Q · filed 2014-08-14 | 1.97M shares 10-Q · filed 2015-08-13 | 2.46M shares 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | 519.00K shares 10-Q · filed 2015-05-13 | |||||
| 2013-12-31 | 0.00 shares 10-K · filed 2016-03-11 | |||||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-12 | 0.00 shares 10-Q · filed 2014-11-12 | ||||
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-14 | 0.00 shares 10-Q · filed 2014-08-14 | ||||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |